CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion · Restricted Stock Units | −9,555 | 0 | ||
| 2021-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion · Restricted Stock Units | −25,290 | 25,290 | ||
| 2021-02-28 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Exercise or conversion · Restricted Stock Units | −30,467 | 60,933 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +2,990 | 72,334 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +9,727 | 82,061 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +26,600 | 108,661 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion | +28,690 | 137,351 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Shares withheld for taxes | −16,560 | $7.19 | $119K | 120,791 |
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −2,990 | 0 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −9,727 | 0 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −26,600 | 26,600 | ||
| 2021-02-28 | TYLE PRAVEEN EVP, R&D | Exercise or conversion · Restricted Stock Units | −28,690 | 57,380 | ||
| 2021-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +1,270 | 66,397 | ||
| 2021-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +4,213 | 70,610 | ||
| 2021-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +8,836 | 79,446 | ||
| 2021-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +13,997 | 93,443 | ||
| 2021-02-28 | Tessmer James F VP, Finance & Accounting | Shares withheld for taxes | −10,765 | $7.19 | $77K | 82,678 |
| 2021-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −1,270 | 0 | ||
| 2021-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −4,213 | 0 | ||
| 2021-02-28 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Restricted Stock Units | −8,836 | 8,837 |
Page 29 of 51 · 1,001 trades